Lion Biotechnologies, Inc. — Form D

Lion Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-06. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Paul KesslerDirectorLos Angeles, CA
David VoytickyDirectorLos Angeles, CA
Merrill McPeakExecutive OfficerNew York, NY
Jay VenkatesanDirectorBoston, MA
Maria FardisDirectorSan Francisco, CA
Maria FardisExecutive OfficerSan Francisco, CA
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Sanford J HillsbergDirectorLos Angeles, CA
Molly C HendersonExecutive OfficerNew York, NY
Michael T LotzeExecutive OfficerNew York, NY
Merrill McPeakDirectorNew York, NY
Steven A FischkoffExecutive OfficerNew York, NY
Wayne J RothbaumDirectorNew York, NY
Ryan J MaynardDirectorNew York, NY
Michael HandelmanDirectorBeverly Hills, CA
Michael HandelmanExecutive OfficerBeverly Hills, CA
Manish SinghDirectorFremont, CA
Manish SinghExecutive OfficerFremont, CA
Sanford HillsbergDirectorWOODLAND HILLS, CA
Mark J AhnDirectorPortland, OR
Merrill A McPeakDirectorKNOXVILLE, TN
Dr. L. Stephen ColesDirectorLOS ANGELES, CA
David A VoytickyDirectorLOS ANGELES, CA
Dr. William Stephen AndrewsDirectorLOS ANGELES, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2016-06-15D$100.0M$100.0M
2013-11-15D$23.3M$23.3M
2011-08-09D$5.0M$5.0M
2011-05-03D$1.0M$500K
2011-01-21D$640K$640K
2010-11-08D$250K$250K
2010-10-01D$500K$500K

More